1.
Villman K, Sjöström J, Heikkilä R, Hultborn R, Malmström P, Bengtsson N-O, et al. TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer. AO [Internet]. 2006 Jan. 1 [cited 2026 Jun. 30];45(5):590-6. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27442